There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.

More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious ...

To receive the full newsletter in your inbox for free sign up here) Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free ...

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma. (HealthDay News) — Neoantigen-targeting personalized ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report. The "personalized cancer vaccines" used by the nine ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed that a new jab could successfully eliminate a type of kidney cancer.

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight advanced kidney cancer. A team of researchers, led by Dr David Braun ...

What if your one kidney fails? "I didn't have all the answers," Devaney said. "All I know is people do this all the time around the world. They donate kidneys and they live a full life." ...